Synthesis and antimicrobial activity of novel quinazolinone-thiazolidine-quinoline compounds

Journal of Saudi Chemical Society

Volumn 17, Issue 3, 2013, Pages 259-267

  Desai, N C ^a   Dodiya, Amit ^a   Shihory, Niraj ^a  

^a BHAVNAGAR UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Quinazolinone derivatives; Quinazolinone thiazolidine quinoline derivatives

Indexed keywords

EID: 84879881565     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2011.04.001     Document Type: Article

References (34)

1. Alafeefy A.M. Synthesis and antimicrobial activity of some new quinazolin-4(3H)-one derivatives. Pharm. Biol. 2008, 46(10):751-756.
2. Andres C.J., Bronson J.J., D'Andrea S.V., Deshpande M.S., Falk P.J., Grant-Young K.A., Harte W.E., Ho H., Misco P.F., Robertson J.G., Stock D., Sun Y., Walsh A.W. 4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurB. Bioorg. Med. Chem. Lett. 2000, 10:715-717.
3. Apfel C., Banner D.W., Bur D., Dietz M., Hubschwerlen C., Locher H., Marlin F., Masciadri R., Pirson W., Stalder H. 2-(2-Oxo-1,4-dihydro-2H-quinazoli-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-6 benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors. J. Med. Chem. 2001, 44:1847-1852.
4. Berber I., Cokmus C., Atalan E. Comparison of Staphylococcus spp. cellular and extracellular proteins. Mikrobiologia 2003, 72:54-59.
5. Bhanot S.K., Singh M., Chaterjee N.R. The chemical and biological aspects of fluoroquinolones: reality and dreams. Curr. Pharm. Des. 2001, 7:311-335.
6. Bogert M.T., Coriner R.A. Researches on quinazolines (Twenty-second paper). On 2-methyl-3-amino-4-quinazolone and certain of its derivatives. J. Am. Chem. Soc. 1909, 31:943-947.
7. Carpenter C.F., Champers H.F. Daptomycin: another novel agent for treating infections due to drug-resistant grampositive pathogens. Clin. Infect. Dis. 2004, 38:994-1000.
8. Chang Z., Babiuk L.A., Hu J. Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date. Bio. Drugs 2007, 21:9-15.
9. Chevalier J., Atifi S., Eyraud A., Mahamoud A., Barbe J., Pajes J. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J. Med. Chem. 2001, 44:4023-4026.
10. Chenard B.L., Welch W.M., Blake J.F., Butler T.W., Reinhold A., Ewing F.E., Menniti F.S., Pagnozzi M.J. Quinazolin-4-one a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tether. J. Med. Chem. 2001, 44:1710-1717.
11. Ctoen-Chackal S., Facompre M., Houssin R., Pommery N., Gossens J.F., Colson P., Bailly C., Henichart J.P. DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents. J. Med. Chem. 2004, 47(14):3665-3673.
12. Edafiogho I.O., Scott K.R., Moore J.A., Farrar Y.A., Nicholson J.M. Synthesis and anticonvulsant activity o imidooxy derivatives. J. Med. Chem. 1991, 34:387-392.
13. Emami S., Shafiee A., Alireza F. Structural features of new quinolones and relationship to antibacterial activity against gram-positive bacteria. Mini Rev. Med. Chem. 2006, 6:375-386.
14. Farror Y.A., Rutkowaka M.C., Grochowski J., Serda P., Pilati T., Cory M., Nicholson J.M., Scott K.R. Synthesis and calculated log P correlation of imidooxy anticonvulsants. J. Med. Chem. 1993, 36:3517-3525.
15. Gary W.W.K., Ting L.F. Bird flu: lessons from SARS. Paediatr. Respir. Rev. 2007, 8:171-176.
16. Guang-Fang X., Bao-An S., Pinaki S.B., Song Y., Pei-Quan Z., Lin-Hong J., Wei X., De-Yu H., Ping L. Synthesis and antifungal activity of novel S-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives. Bioorg. Med. Chem. 2007, 15:3768-3774.
17. Gursoy A., Otuk G., Terzioglu N. Synthesis and antimicrobial evaluation of some novel imidazolylmercaptoacetylthiosemicarbazide and 4-thiazolidinone analogs. Turkish J. Pharm. Sci. 2005, 2:1-10.
18. Hardman J.G., Limbird E.L., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's. The Pharmacological Basis of Therapeutics 2002, Springer, p. 1065. ninth ed.
19. Hooper D.C. Quinolones. Bennett's Principles and Practice of Infectious Diseases 1995, 364. Churchill Livingstone Inc., New York. forth ed. Mandell, Douglas (Eds.).
20. Hooper D.C., Wolfson J.S. Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 1989, 2:378-424.
21. Pan B., Huang R.Z., Ying H.J. Design, synthesis and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones. Bioorg. Med. Chem. Lett. 2010, 20:2461-2464.
22. Raffa D., Daidone G., Schillaci D., Maggio B., Plescia F. Synthesis of new 3-(3-phenyl-isoxazo-5-yl) or 3-[(3-phenylisoxazol-5-yl)-amino]-substituted 4(3H)quinazoli- none derivatives with antineoplastic activity. Pharmazie 1999, 54:251-254.
23. Rao A., Zappala M. Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors. Arkivoc 1999, v:147-155.
24. Rattan A. Antimicrobials in laboratory medicine 2000, Churchill, B.I., Livingstone, New Delhi, pp. 85-105.
25. Sayyed M., Mokle S. Synthesis of some new 2,3-diaryl-1,3-thiazolidin-4-ones as antibacterial agents. Arkivoc 2006, ii:187-192.
26. Siddappa K., Reddy K., Reddy C.V. Synthesis, characterization and antimicrobial studies of 3-[(2-hydroxy-quinolin-3-ylmethylene)-amino]-2-phenyl-3H-quinazolin-4-one and its Metal(II) complexes. E-J. chem. 2008, 5:155-162.
27. Surrey A.R. 4-Thiazolidones. IV. The preparation of some 3-alkylaminoalkyl-2-aryl derivatives. J. Am. Chem. Soc. 1949, 71:3354-3356.
28. Taun P.T., Edmund L.E., Joseph P.S., Brian M.W., Michael A.S., Hollis S., John M.D., Martin A.S., Themis J., Stephen J.G., Dai Q.N., Paul B., Judy Y., Anurag S., Chan H., Saeed R., Xiujuan W., Rajeshwar S. Structure activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors. Bioorg. Med. Chem. Lett. 2007, 17:1312-1320.
29. Troutman H.D., Long L.M. The Synthesis of 2,3-disubstituted-4-thiazolidones. J. Am. Chem. Soc. 1948, 70:3436-3439.
30. Tobe M., Isobe Y., Tomizawa H., Nagasaki T., Obara F., Hayashi H. Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF alpha production and T cell proliferation. Bioorg. Med. Chem. 2003, 11:609-616.
31. Weigelt J., Itani K., Stevens D., Lau W., Dryden M., Knirsch C. Linzolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 2005, 49:2260-2266.
32. Wolfgang L. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmcol. 1998, 342:1-13.
33. Yeung K.S., Meanwell N.A. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus. Infect. Dis. 2007, 7:29-41.
34. Youssef A.M., White M.S., Klegeris A. Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents. Biorg. Med. Chem. 2010, 20:2019-2028.